Amag Pharmaceuticals, Inc.

Formerly NASDAQ: AMAG
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 70 pages Portions of This Exhibit Have Been Redacted Because They Are Both (I) Not Material and (II) Would Likely Cause Competitive Harm to the Company if Publicly Disclosed. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark "[***]". License and Commercialization Agreement
12/34/56
EX-10.1
from 8-K 25 pages Termination Agreement
12/34/56
EX-10.1
from 8-K 56 pages Asset Purchase Agreement by and Between AMAG Pharmaceuticals, Inc. and Millicent Pharma Limited May 21, 2020
12/34/56
EX-10.5
from 10-Q 4 pages Amag Pharmaceuticals, Inc. Restricted Stock Unit Award Agreement Non-Plan Inducement Grant
12/34/56
EX-10.4
from 10-Q 6 pages Amag Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement Non-Plan Inducement Grant
12/34/56
EX-10.3
from 10-Q 1 page Material contract
12/34/56
EX-10.1
from 8-K 16 pages Employment Agreement
12/34/56
EX-10.24
from 10-K 162 pages Bay Colony Corporate Center 1100 Winter Street Waltham, Massachusetts Lease Dated June 10, 2013
12/34/56
EX-10.20
from 10-K 11 pages Employment Agreement
12/34/56
EX-10.15
from 10-K 4 pages Amag Pharmaceuticals, Inc. Restricted Stock Unit Award Agreement (Deferred) for Non-Employee Directors
12/34/56
EX-10.14
from 10-K 5 pages Amag Pharmaceuticals, Inc. Restricted Stock Unit Award Agreement for Non-Employee Directors
12/34/56
EX-10.13
from 10-K 6 pages Amag Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Non-Employee Directors
12/34/56
EX-10.12
from 10-K 4 pages Amag Pharmaceuticals, Inc. Restricted Stock Unit Award Agreement for Company Employees
12/34/56
EX-10.11
from 10-K 6 pages Amag Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Company Employees
12/34/56
EX-10.10
from 10-K 6 pages Amag Pharmaceuticals, Inc. Incentive Stock Option Agreement for Company Employees
12/34/56
EX-10.1
from 8-K 3 pages Material contract
12/34/56
EX-10.4
from 10-Q 3 pages Portions of This Exhibit Have Been Redacted Because They Are Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”
12/34/56
EX-10.3
from 10-Q 31 pages Portions of This Exhibit Have Been Redacted Because They Are Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Manufacturing Services Agreement
12/34/56
EX-10.2
from 10-Q 30 pages Portions of This Exhibit Have Been Redacted Because They Are Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Supply Agreement Effective as of 20 December 2018 ("Effective Date") Between
12/34/56
EX-10.1
from 10-Q 30 pages Portions of This Exhibit Have Been Redacted Because They Are Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Commercial Supply Agreement
12/34/56